GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.
You can purchase shares of GlycoMimetics (NASDAQ:GLYC) through any online brokerage.
Other companies in GlycoMimetics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and Curis (NASDAQ:CRIS).
GlycoMimetics has a consensus price target of $12.00.
The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.4107 last updated November 15, 2024 at 7:57 PM EST.
There are no upcoming dividends for GlycoMimetics.
GlycoMimetics’s Q2 earnings are confirmed for Monday, January 6, 2025.
There is no upcoming split for GlycoMimetics.
GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.